Examkin

Soru

Zorluk: OrtaNephrology

During a routine health maintenance examination, laboratory testing is performed on a 58-year-old man with a long-standing history of type 2 diabetes mellitus and essential hypertension. The patient reports feeling entirely well and denies any recent illness, changes in urine output, or gastrointestinal symptoms. His current medication regimen consists of metformin, lisinopril, amlodipine, and rosuvastatin. Vital signs show a blood pressure of 134/82 mm Hg and a heart rate of 72/min. There is no peripheral edema on examination. The basic metabolic panel and urinalysis results are as follows:

Serum sodium: 138138 mEq/L
Serum potassium: 5.85.8 mEq/L
Serum chloride: 110110 mEq/L
Serum bicarbonate: 1818 mEq/L
Blood urea nitrogen: 2626 mg/dL
Serum creatinine: 1.71.7 mg/dL
Fasting glucose: 148148 mg/dL
Urine pH: 5.25.2

Which of the following is the most likely primary mechanism for this patient's laboratory abnormalities?

  1. Reduced production and effect of aldosteroneCevap
  2. B
    Impaired distal tubular secretion of hydrogen ions
  3. C
    Defective proximal tubular reabsorption of bicarbonate
  4. D
    Accumulation of unmeasured metabolic organic anions
  5. E
    Loss of bicarbonate-rich fluids from the lower gastrointestinal tract

Cevap

Reduced production and effect of aldosterone (Type 4 Renal Tubular Acidosis)
This patient has a normal anion gap metabolic acidosis (NAGMA) with hyperkalemia and a urine pH less than 5.5, which is the classic presentation of Type 4 renal tubular acidosis (RTA). In patients with long-standing diabetes mellitus, mild to moderate kidney damage often impairs renin release from the juxtaglomerular apparatus, resulting in hyporeninemic hypoaldosteronism. The concurrent use of an angiotensin-converting enzyme (ACE) inhibitor, such as lisinopril, further suppresses aldosterone production. Aldosterone deficiency decreases sodium reabsorption and potassium secretion in the principal cells of the collecting duct, leading to hyperkalemia. This hyperkalemia impairs ammonia synthesis in the proximal tubule, reducing the availability of urinary buffers (NH3/NH4+) needed for daily acid excretion, ultimately resulting in a non-anion gap metabolic acidosis.

Adım Adım Çözüm

1
Calculate the serum anion gap to classify the metabolic acidosis.
Anion gap = Sodium - (Chloride + Bicarbonate) = 138 - (110 + 18) = 10 mEq/L.
An anion gap of 10 mEq/L is within the normal reference range (8-12 mEq/L), categorizing the disturbance as a non-anion gap metabolic acidosis (NAGMA).
2
Evaluate the serum potassium level and urine pH in the context of NAGMA.
The patient has hyperkalemia (Potassium = 5.8 mEq/L) and an appropriately acidic urine (pH = 5.2).
The presence of hyperkalemia with NAGMA strongly points to Type 4 Renal Tubular Acidosis (RTA). Type 1 and Type 2 RTAs typically present with hypokalemia.
3
Correlate the laboratory findings with the patient's medical history and medications.
The patient has long-standing diabetes mellitus and is taking an ACE inhibitor (lisinopril).
Diabetic nephropathy frequently damages the juxtaglomerular apparatus, leading to a state of hyporeninemic hypoaldosteronism. ACE inhibitors further decrease aldosterone levels, directly causing the Type 4 RTA presentation.

Anahtar Kavram

Type 4 Renal Tubular Acidosis (Hyperkalemic RTA)
Bu soruyu puanla

Konular

Nephrology

Bu konudan daha fazla soru